Blue chip – Sweet As A Biscuit http://sweetasabiscuit.com/ Wed, 01 Dec 2021 19:02:35 +0000 en-US hourly 1 https://wordpress.org/?v=5.8 https://sweetasabiscuit.com/wp-content/uploads/2021/10/icon-14-120x120.png Blue chip – Sweet As A Biscuit http://sweetasabiscuit.com/ 32 32 Sveti Stefan Hoteli tops Montenegro’s top winners in November https://sweetasabiscuit.com/sveti-stefan-hoteli-tops-montenegros-top-winners-in-november/ Wed, 01 Dec 2021 08:33:00 +0000 https://sweetasabiscuit.com/sveti-stefan-hoteli-tops-montenegros-top-winners-in-november/ PODGORICA (Montenegro), December 1 (SeeNews) – Montenegrin hotel operator Sveti Stefan Hoteli [MNG:SSHO] dominated blue chip winners on the Montenegrin stock exchange in November, as stock indexes ended lower, according to exchange data. The Montenegrin Stock Exchange’s premier index, MNSE10, closed down 1.75% in November at 763.59 points. The MONEX benchmark, which tracks the 20 […]]]>

PODGORICA (Montenegro), December 1 (SeeNews) – Montenegrin hotel operator Sveti Stefan Hoteli [MNG:SSHO] dominated blue chip winners on the Montenegrin stock exchange in November, as stock indexes ended lower, according to exchange data.

The Montenegrin Stock Exchange’s premier index, MNSE10, closed down 1.75% in November at 763.59 points.

The MONEX benchmark, which tracks the 20 most representative stocks on the Montenegro Stock Exchange, fell 6.06% in November and closed at 10,563.62 points.

A total of 3,280 Sveti Stefan Hoteli shares changed hands for a turnover of 9,911 euros in November. Sveti Stefan Hoteli gained 3.33% to 3.0216 euros.

Crnogorski Telekom [MNG:TECG] punctuated the first-rate declines in November, with its share price falling 2.90% over the month to 1.1465 euros. In total, 35,390 shares of the company changed hands, generating a turnover of 40,574 euros.

The exchange’s total turnover rose in November to 5.891 million euros (6.669 million euros) from 5.814 euros a month earlier.

A total of 124 deals were completed on the Podgorica Stock Exchange in November, up from 118 in October. Market capitalization stood at 3.136 billion euros at the end of November, up from 3.207 billion euros a month earlier.

($ = 0.85873 euro)


Source link

]]>
Most Romanian stock indices recover, Nuclearelectrica tops blue chip winners https://sweetasabiscuit.com/most-romanian-stock-indices-recover-nuclearelectrica-tops-blue-chip-winners/ Mon, 29 Nov 2021 15:49:00 +0000 https://sweetasabiscuit.com/most-romanian-stock-indices-recover-nuclearelectrica-tops-blue-chip-winners/ BUCHAREST (Romania), Nov.29 (SeeNews) – Most Romanian stock indices closed the trading session on Monday in the green, as nuclear power plant producer Nuclearelectrica [BSE:SNN] led top-notch winners, data from the Bucharest Stock Exchange, BVB said. Total turnover of BVB shares amounted to 117.5 million lei ($ 27 million / 24 million euros) on Monday, […]]]>

BUCHAREST (Romania), Nov.29 (SeeNews) – Most Romanian stock indices closed the trading session on Monday in the green, as nuclear power plant producer Nuclearelectrica [BSE:SNN] led top-notch winners, data from the Bucharest Stock Exchange, BVB said.

Total turnover of BVB shares amounted to 117.5 million lei ($ 27 million / 24 million euros) on Monday, compared to 60.4 million lei on Friday, according to the BVB website. .

Nuclearelectrica dominated the big winners on Monday as its share price jumped 6.91% to 43.3 lei.

Prime lender Banca Transilvania [BSE:TLV] increased 0.40% to 2.48 lei, achieving the highest turnover of the session, of 25.6 million lei.

Leading private healthcare provider MedLife [BSE:M] gained 3.29% to 22 lei in the second highest turnover of the day of 17.5 million lei.

Romanian consumer goods distribution and logistics company Aquila [BSE:AQ] traded at 5.46 lei in its first session on BVB in the third highest turnover of the day of 12.12 million lei. The listing took place after the successful conclusion of an Initial Public Offering (IPO) worth 367 million lei – the largest to date by an entrepreneurial company in the Romanian capital market.

Details follow:

BET 12,195.61 0.15%
BET-TR 21,582.21 0.15%
PARI-BK 2422.50 0.42%
BET-FI 51,272.92 0.89%
PARI-NG 809.91 -0.16%
PARI-XT 1,077.20 0.11%
PARI-XT-TR 1905.67 0.11%
ROTX 25,804.71 -0.16%
BETAeRO 983.02 1.84%

BET is the first index developed by BVB and represents the benchmark index for the local capital market. The BET reflects the performance of the most traded companies on the BVB regulated market, excluding financial investment companies (SIF). It now includes 20 companies.

BET-TR is the first total return index launched by BVB. It is based on the structure of the benchmark BET market index. BET-TR tracks changes in the price of its component shares and is adjusted to also reflect dividends paid by the constituent companies.

The BET-FI is the first sector index launched by the BVB and reflects the price variations of RIS and other similar entities.

BET-BK has been designed to be used as a benchmark by asset managers and other institutional investors.

BET-NG is a sector index that reflects the evolution of all companies listed on BVB’s regulated market included in the energy and related utilities sector. The maximum index weight that a company can hold is 30%.

BET-XT tracks the price movements of the 25 most listed companies on the BVB regulated market, including RIS.

BET-XT-TR is the total return version of the BET-XT index, which includes the 25 most traded Romanian companies listed on the BVB.

ROTX is an index developed by BVB in collaboration with the Vienna Stock Exchange. It follows, in real time, the price changes of blue chip shares traded on the Bucharest Stock Exchange.

BET AeRO is the first index for the AeRO market developed by BVB that reflects the price performance of representative companies listed on the AeRO market that meet the criteria of liquidity and free float market capitalization. It is a free float market capitalization weighted index, with a maximum weighting of 15% for any component of the index.

(1 euro = 4.9490 lei)

Banca Transilvania SA is one of the largest banks in South East Europe. For more references, take a look at the Top 100 Banks


Source link

]]>
3 Best-in-Class Resilient Stocks to Buy Now https://sweetasabiscuit.com/3-best-in-class-resilient-stocks-to-buy-now/ Sat, 27 Nov 2021 11:04:29 +0000 https://sweetasabiscuit.com/3-best-in-class-resilient-stocks-to-buy-now/ Blue-chip, resilient stocks are attractive in today’s market environment What are some of the typical qualities that make a business resilient? It is generally a business that can generate profits in almost any economic environment. With a strong brand and products or services that are always in constant demand, investors can count on these types […]]]>

Blue-chip, resilient stocks are attractive in today’s market environment

What are some of the typical qualities that make a business resilient? It is generally a business that can generate profits in almost any economic environment. With a strong brand and products or services that are always in constant demand, investors can count on these types of businesses through thick and thin. Blue-chip stocks are a good example of this, as they are companies with strong balance sheets, stable cash flows, and business models that can stand the test of time.

Adding resilient blue-chip stocks to your portfolio makes a lot of sense right now given recent market volatility. With so many confusing factors at play in the market and the economy, targeting companies that offer reliability might be one of the smartest things to do right now.

Let’s take a look at 3 resilient blue-chip stocks to buy now.

If you are interested in a top tech company that has consistently proven that it can adapt to new trends over the years, Microsoft certainly fits the bill. The software company has pivoted to cloud computing at the perfect time, and Microsoft Azure now offers whole new growth opportunities for long-term shareholders. Products like Windows, Microsoft Office, Office 365, Sharepoint, and more are some of the world’s most popular business software options, which means the business is consistently getting the cash flow it can. reinvest in high-growth areas such as Azur.

Microsoft’s revenue grew 22% year-over-year in the second quarter to $ 45.3 billion, and the company continues to reward its shareholders with consistent profit growth. There’s also a lot to like about the company’s XBOX Series X gaming console, which could deliver a nice increase in profits for Microsoft as supply chain issues start to diminish. The bottom line here is that Microsoft has a rock solid net cash position, strong upward growth, and a history of building innovative new products, making it one of the best blue chip stocks around. .

Even with Pfizer trading around all-time highs, this blue chip company could end up being a good deal at current levels. It is a global research-based biopharmaceutical company that offers investors the right balance between a strong existing drug portfolio and an intriguing pipeline of new drugs that could become future cash cows. With top-selling drugs like Prevnar, Ibrance and Eliquis, investors here can count on stable earnings quarter after quarter. Global prescription drug sales are expected to grow at a compound annual growth rate of 7.4% from 2020 to 2026, indicating that there is a lot of money to be made for a company like Pfizer.

Investors are likely already aware of the company’s COVID-19 vaccine, which saw Pfizer increase revenue 134% year-on-year to $ 24.1 billion in the third quarter. The company’s COVID antiviral treatment pills could be another strong growth driver, and FDA approval of the treatment could cause stocks to skyrocket in the coming weeks. Finally, the company’s 3.05% dividend yield is very attractive, and Pfizer also has a history of stock buyback programs that make it a great choice for long-term investors.

Companies involved in the healthcare industry can certainly offer reliability, especially in the aftermath of the global pandemic. McKesson is a solid choice as the largest pharmaceutical distributor in North America, which means the company plays a vital role in keeping our country healthy. In addition to pharmaceuticals, McKesson provides health information technology, medical supplies, and care management tools, which means it serves a wide range of healthcare clients. What is perhaps most appealing here is the fact that McKesson has a truly dominant position in the market, as it is one of the three companies that operate as a pharma wholesale and distribution oligarchy. .

The company reported total second-quarter revenue of $ 66.6 billion, up 9% year-on-year, and raised its outlook for fiscal 22, which is another good reason to consider adding actions. McKesson also plays an important role in the fight against COVID-19 and has seen strong demand for products such as COVID-19 tests, vaccines and more in recent quarters. Finally, the fact that McKesson is selling part of its European business is another advantage to consider, as it will allow the company to focus on the areas with the highest growth in the business in the future.

Should you invest $ 1,000 in McKesson now?

Before you consider McKesson, you’ll want to hear this.

MarketBeat tracks Wall Street’s top-rated and top-performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts quietly whisper to their clients to buy now before the broader market takes hold … and McKesson was not on the list.

While McKesson currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better bets.

See the 5 actions here

Companies mentioned in this article

Compare these actions Add these actions to my watchlist


Source link

]]>
One United Properties top Bucharest Stock Exchange blue chip winners, stock indices continue to climb https://sweetasabiscuit.com/one-united-properties-top-bucharest-stock-exchange-blue-chip-winners-stock-indices-continue-to-climb/ Thu, 25 Nov 2021 16:57:00 +0000 https://sweetasabiscuit.com/one-united-properties-top-bucharest-stock-exchange-blue-chip-winners-stock-indices-continue-to-climb/ BUCHAREST (Romania), November 25 (SeeNews) – Romanian real estate developer One United Properties [BSE:ONE] Bucharest Stock Exchange (BVB) blue chip winners on Thursday showed stock exchange data. Total turnover from BVB shares stood at some 31 million lei ($ 7 million / 6 million euros) on Thursday, compared to 27.8 million lei on Wednesday, according […]]]>

BUCHAREST (Romania), November 25 (SeeNews) – Romanian real estate developer One United Properties [BSE:ONE] Bucharest Stock Exchange (BVB) blue chip winners on Thursday showed stock exchange data.

Total turnover from BVB shares stood at some 31 million lei ($ 7 million / 6 million euros) on Thursday, compared to 27.8 million lei on Wednesday, according to the BVB website.

One United Properties led the blue chip winners, increasing 5.71% to 2.5 lei in the largest commercial turnover during the session of 6.3 million lei.

TTS Premier Freight Forwarder [BSE:TTS] traded 4.93% higher to 24.5 lei in the second highest turnover of the day of 4.82 million lei.

Prime lender Banca Transilvania [BSE:TLV] gained 0.20% to 2.5250 lei in the third highest turnover of the day of 4.05 million lei.

Details follow:

BET 12,607.30 0.57%
BET-TR 22,308.81 0.57%
BET-FI 51,777.20 0.00%
PARI-NG 846.09 0.30%
PARI-XT 1,112.86 0.53%
PARI-XT-TR 1,968.28 0.53%
PARI-BK 2493.56 0.64%
ROTX 26,797.43 0.37%
BETAeRO 984.62 -0.24%

BET is the first index developed by BVB and represents the benchmark index for the local capital market. The BET reflects the performance of the most traded companies on the BVB regulated market, excluding financial investment companies (SIF). It now includes 20 companies.

BET-TR is the first total return index launched by BVB. It is based on the structure of the benchmark BET market index. BET-TR tracks changes in the price of its component shares and is adjusted to also reflect dividends paid by the constituent companies.

The BET-FI is the first sector index launched by the BVB and reflects the price variations of RIS and other similar entities.

BET-BK has been designed to be used as a benchmark by asset managers and other institutional investors.

BET-NG is a sector index that reflects the evolution of all companies listed on BVB’s regulated market included in the energy and related utilities sector. The maximum index weight that a company can hold is 30%.

BET-XT tracks the price movements of the 25 most listed companies on the BVB regulated market, including RIS.

BET-XT-TR is the total return version of the BET-XT index, which includes the 25 most traded Romanian companies listed on the BVB.

ROTX is an index developed by BVB in collaboration with the Vienna Stock Exchange. It follows, in real time, the price changes of blue chip shares traded on the Bucharest Stock Exchange.

BET AeRO is the first index for the AeRO market developed by BVB that reflects the price performance of representative companies listed on the AeRO market that meet the criteria of liquidity and free float market capitalization. It is a free float market capitalization weighted index, with a maximum weighting of 15% for any component of the index.

(1 euro = 4.9490 lei)

Banca Transilvania SA is one of the largest banks in South East Europe. For more references, take a look at the Top 100 Banks


Source link

]]>
Analysts name 2 blue-chip ASX 200 stocks to buy now https://sweetasabiscuit.com/analysts-name-2-blue-chip-asx-200-stocks-to-buy-now/ Mon, 22 Nov 2021 23:45:00 +0000 https://sweetasabiscuit.com/analysts-name-2-blue-chip-asx-200-stocks-to-buy-now/ Image source: Getty Images Luckily for investors, the Australian equity market is home to a good number of high-quality, blue-chip stocks to choose from. Two top-notch ASX 200 stocks that might be worth considering additions to your portfolio right now are listed below. Here’s what you need to know about them: The first top-notch ASX […]]]>

Image source: Getty Images

Luckily for investors, the Australian equity market is home to a good number of high-quality, blue-chip stocks to choose from.

Two top-notch ASX 200 stocks that might be worth considering additions to your portfolio right now are listed below. Here’s what you need to know about them:

The first top-notch ASX 200 stock to look at is BHP. The Big Australian is one of the largest mining operators in the world and has a diverse portfolio of world-class, low-cost operations across the globe. With favorable prices for most of the raw materials it produces, BHP appears well positioned to generate significant free cash flow again in fiscal 2022. This despite the recent decline in iron ore prices. This could make the recent weakness in the BHP share price a buying opportunity for investors.

The Macquarie team certainly believe that is the case. The broker currently has an outperformance rating and a price target of $ 52.00 on the miner’s stock. Macquarie also expects BHP’s free cash flow generation to be strong enough to support a 10% dividend yield in FY 2022 at the current share price.

National Australia Bank Ltd (ASX: NAB)

NAB is another top notch stock from the ASX 200 that is well rated. While the banking sector has fallen out of favor with investors following the recent round of earnings releases, many analysts remain positive on the NAB. This is due to the progress of its cost management initiatives and its strong position in investment / commercial banking.

Goldman Sachs is one of the more bullish brokers. He believes that NAB’s cost management initiatives (which he says are still ahead of his peers) have freed up capital spending to be more customer experience oriented. Additionally, the broker likes NAB because of its position as the largest merchant bank. This is due to Goldman’s belief that retail-oriented banks will struggle to face aggressive competition for mortgages.

Overall, NAB is the broker’s top pick among the Big Four banks and has a conviction buy rating and a price target of $ 31.15 on its shares.


Source link

]]>
Should you buy this Blue Chip Biotech share? https://sweetasabiscuit.com/should-you-buy-this-blue-chip-biotech-share/ Sun, 21 Nov 2021 13:00:00 +0000 https://sweetasabiscuit.com/should-you-buy-this-blue-chip-biotech-share/ This is arguably the most difficult time for an income investor in decades. On the one hand, the S&P 500 returns less than 1.3%, which is very close to its all-time low of 1.1% in 2000. At the same time, the annual inflation rate of 6.2% last month hit a 31-year high. Anyone sitting on […]]]>

This is arguably the most difficult time for an income investor in decades. On the one hand, the S&P 500 returns less than 1.3%, which is very close to its all-time low of 1.1% in 2000. At the same time, the annual inflation rate of 6.2% last month hit a 31-year high. Anyone sitting on cash and waiting for a market correction is like watching your money soar as your capital loses purchasing power. So what should an income investor do?

Fortunately, there are still some viable, high yielding options that income investors can consider. Let’s take a look at three reasons why pharmaceutical stocks AbbVie (NYSE: ABBV) could be one of those options.

Image source: Getty Images.

AbbVie consistently exceeds expectations

When AbbVie released its third quarter results on October 29, the company managed to beat non-GAAP analyst earnings and earnings per share (EPS) estimates for the 11th consecutive quarter. The company posted third-quarter revenue of $ 14.34 billion, equivalent to a growth rate of 11.3% compared to the same period last year. That’s what led AbbVie to beat analysts’ forecast of $ 14.3 billion in third-quarter revenue by 0.3%.

AbbVie’s largest segment, the immunology segment led by Humira, followed by Skyrizi and Rinvoq, contributed 60.5% of total revenue growth in the third quarter. Humira’s revenue grew 5.6% year-over-year to $ 5.43 billion in the third quarter, contributing nearly one-third (32.2%) of the revenue growth in AbbVie’s immunology segment in the third quarter.

Without a doubt, AbbVie’s most encouraging third quarter result is that its next-generation immunology drugs Skyrizi and Rinvoq saw their combined revenue increase 92.2% to $ 1.25 billion. This represented the remaining 67.8% of the growth in the immunology segment. And before Humira’s US patent expires in 2023, Skyrizi and Rinvoq’s overall share of immunology segment revenue increased from 11.2% to 18.7% in the third quarter.

Overall, AbbVie appears well positioned to rebound strongly after Humira’s imminent loss of exclusivity in the United States via Skyrizi, Rinvoq and other drugs such as the antipsychotic Vraylar, which increased its revenue. third-quarter 29% year-over-year to $ 461 million. That’s why analysts predict that AbbVie will show annual adjusted EPS growth of 4.5% over the next five years despite the fall in Humira’s patents. AbbVie reported third quarter adjusted EPS of $ 3.33, representing a growth rate of 17.7% from the previous year. It also beat analyst consensus of $ 3.22 in third quarter adjusted EPS by 3.4%.

AbbVie’s strong performance in the third quarter and year-to-date prompted the company to slightly raise its midpoint forecast for Adjusted EPS for this year, from $ 12.57 to $ 12.65. The updated mid-term forecast for this year would be a 19.8% year-over-year growth rate in adjusted EPS from the $ 10.56 reported last year. These encouraging prospects help to explain why the board of directors of the company announced a sharp increase of 8.5% of its quarterly dividend as of the dividend paid next February.

A fair and improving balance sheet

AbbVie is a growing company, which is important for dividend growth investors. But does the company have a sufficiently healthy balance sheet to pay its dividend during a temporary drop in profitability? Let’s turn to the interest coverage ratio to answer this question, which measures the ease with which a company can meet its interest expense obligations with its earnings before interest and taxes (EBIT).

Its interest coverage ratio fell from four in the first nine months of last year ($ 6.57 billion in EBIT / $ 1.66 billion in interest expense) to 5.8 over the course of the last year. the first nine months of this year ($ 10.53 billion EBIT / $ 1.81 billion interest expense). This demonstrates that the company continues to move in the right direction in integrating Allergan’s assets into its business after the acquisition closes in May 2020.

A blue chip at an attractive price

Even though AbbVie’s fundamentals seem solid, the stock is strongly discounted by the market. Primarily motivated by concerns over the cliff of Humira’s US patents which I think are exaggerated based on Skyrizi and Rinvoq’s huge growth trajectories.

In fact, AbbVie’s forward P / E ratio of 8.4 at its current price of $ 116 per share is much lower than the drugmaker’s average forward P / E ratio of 11.3. This gives income investors a chance to pick up AbbVie shares and its well-hedged 4.5% return before the market warms up and puts it to a higher valuation multiple.

This article represents the opinion of the author, who may disagree with the “official” recommendation position of a premium Motley Fool consulting service. We are heterogeneous! Questioning an investment thesis – even one of our own – helps us all to think critically about investing and make decisions that help us become smarter, happier, and richer.


Source link

]]>
Romgaz leads first-rate declines on Bucharest stock exchange, stock indices end week in the red https://sweetasabiscuit.com/romgaz-leads-first-rate-declines-on-bucharest-stock-exchange-stock-indices-end-week-in-the-red/ Fri, 19 Nov 2021 17:43:00 +0000 https://sweetasabiscuit.com/romgaz-leads-first-rate-declines-on-bucharest-stock-exchange-stock-indices-end-week-in-the-red/ BUCHAREST (Romania), November 19 (SeeNews) – Romanian private healthcare provider Romgaz [BSE:SNG], led the declines among the Bucharest Stock Exchange (BVB) blue chips on Friday, according to stock exchange data. Total turnover of BVB shares amounted to some 47.5 million lei ($ 10.9 million / 9.6 million euros) on Friday, compared to 51 million lei […]]]>

BUCHAREST (Romania), November 19 (SeeNews) – Romanian private healthcare provider Romgaz [BSE:SNG], led the declines among the Bucharest Stock Exchange (BVB) blue chips on Friday, according to stock exchange data.

Total turnover of BVB shares amounted to some 47.5 million lei ($ 10.9 million / 9.6 million euros) on Friday, compared to 51 million lei on Thursday, the report said. BVB website.

Romgaz dominated the blue chip declines on Friday, as its share price fell 2.79% to 34.8 lei.

Romanian real estate developer One United Properties [BSE:ONE] share price rose 1.24% to 2.6 lei in the largest trading turnover during the session, to 23.09 million lei. One United announced on Friday to indirectly acquire 54.43% of the local shopping center Bucur Obor SA [BSE:BUCU] for 65 million lei.

Prime lender Banca Transilvania [BSE:TLV] fell 0.38% to 2.59 lei to reach the second turnover of the day with 4.11 million lei.

The premier oil and gas group OMV Petrom [BSE:SNP] traded 2.24% down to 0.4795 lei in the third highest turnover of the day of 3.36 million lei.

Details follow:

BET 12,559.61 -1.51%
BET-TR 22,227.10

-1.50%

BET-FI 51,705.29 -0.84%
PARI-NG 849.17 -2.10%
PARI-XT 1,109.15 -1.44%
PARI-XT-TR 1,962.20 -1.43%
PARI-BK 2475.31 -1.42%
ROTX 26,830.36 -1.73%
BETAeRO 1,009.00 -0.44%

-1.50%

BET is the first index developed by BVB and represents the benchmark index for the local capital market. The BET reflects the performance of the most traded companies on the BVB regulated market, excluding financial investment companies (SIF). It now includes 20 companies.

BET-TR is the first total return index launched by BVB. It is based on the structure of the benchmark BET market index. BET-TR tracks changes in the price of its component shares and is adjusted to also reflect dividends paid by the constituent companies.

The BET-FI is the first sector index launched by the BVB and reflects the price variations of RIS and other similar entities.

BET-BK has been designed to be used as a benchmark by asset managers and other institutional investors.

BET-NG is a sector index which reflects the evolution of all companies listed on BVB’s regulated market included in the energy and related utilities sector. The maximum index weight that a company can hold is 30%.

BET-XT tracks the price changes of the 25 most listed companies on the BVB regulated market, including RIS.

BET-XT-TR is the total return version of the BET-XT index, which includes the 25 most traded Romanian companies listed on the BVB.

ROTX is an index developed by BVB in collaboration with the Vienna Stock Exchange. It follows, in real time, the price changes of blue chip shares traded on the Bucharest Stock Exchange.

BET AeRO is the first index for the AeRO market developed by BVB that reflects the price performance of representative companies listed on the AeRO market that meet the criteria of liquidity and free float market capitalization. It is a free float market capitalization weighted index, with a maximum weight of 15% for any component of the index.

(1 euro = 4.9490 lei)

Banca Transilvania SA is one of the largest banks in South East Europe. For more references, take a look at the Top 100 Banks


Source link

]]>
Sofia stock indices close lower, Eurohold tops blue chip declines https://sweetasabiscuit.com/sofia-stock-indices-close-lower-eurohold-tops-blue-chip-declines/ Wed, 17 Nov 2021 15:05:00 +0000 https://sweetasabiscuit.com/sofia-stock-indices-close-lower-eurohold-tops-blue-chip-declines/ SOFIA (Bulgaria), Nov. 17 (SeeNews) – All Bulgarian Stock Exchange (ESB) indices fell on Wednesday, with the SOFIX index losing 0.43% to 608.61 points. SOFIX was mainly pulled down by a 2.78% drop in shares of financial and energy group Eurohold Bulgaria [BUL:EUGBG]. In total, 5,140 Eurohold shares traded at an average price of 2.1299 […]]]>

SOFIA (Bulgaria), Nov. 17 (SeeNews) – All Bulgarian Stock Exchange (ESB) indices fell on Wednesday, with the SOFIX index losing 0.43% to 608.61 points.

SOFIX was mainly pulled down by a 2.78% drop in shares of financial and energy group Eurohold Bulgaria [BUL:EUGBG]. In total, 5,140 Eurohold shares traded at an average price of 2.1299 lev. A day earlier, Eurohold gained 4.85%.

A 4.55% drop in fertilizer producer Neochim [BUL:NEOH] weighed on the BGBX40 index, which tracks the 40 most traded stocks on the Sofia Stock Exchange, and the BGTR30 index, in which companies with a free float of at least 10% have equal weight.

The BGBX40 fell 0.34% to 138.27 points, while the BGTR30 fell 0.13% to 665.11 points.

The BGREIT index, which tracks seven real estate investment trusts, closed down 0.25% at 166.11 points on Wednesday due to a 0.93% drop in the share price of Bulgarian real estate fund REIT [BUL:BREF].

Total turnover in the main BSE market rose to 1.5 million levs (866,300/766,900 euros) on Wednesday from 1.3 million levs on Tuesday.

The most traded company on Wednesday was real estate company Velgraf Asset Management [BUL:VAM]. No less than 95,500 shares of the company traded 0.47% less at an average price of 4.2,800 Lev, generating 408,700 Lev in turnover for the day.

(1 euro = 1.95583 lev)


Source link

]]>
J & J’s corporate split: just another big, top-notch breakup https://sweetasabiscuit.com/j-js-corporate-split-just-another-big-top-notch-breakup/ Fri, 12 Nov 2021 19:09:21 +0000 https://sweetasabiscuit.com/j-js-corporate-split-just-another-big-top-notch-breakup/ Investors who buy and hold dividends can be forgiven if they feel like they’ve seen it already. After all, if it seems like many of our most iconic blue chip dividend payers are declining by the day… well, that’s because they are. Health giant Johnson & johnson (JNJ, $ 163.06) on Friday announced plans to […]]]>

Investors who buy and hold dividends can be forgiven if they feel like they’ve seen it already. After all, if it seems like many of our most iconic blue chip dividend payers are declining by the day… well, that’s because they are.

Health giant Johnson & johnson (JNJ, $ 163.06) on Friday announced plans to split into two separate companies, joining a growing list of illustrious companies that are splitting up to boost growth.

The move comes just a day later General Electric (GE, $ 107.00) said it will split into three companies over the next several years.

The trend hardly stops there. In fact, Dow stocks, old Dow stocks, the S&P 500 dividend aristocrats (companies that have increased their payouts every year for at least 25 years) and other dividend stalwarts trying to get a division addition. do not miss.

More on that in a moment.

Johnson & Johnson’s plan

In the most recent case, Johnson & Johnson plans to separate its consumer health business – the one that makes Tylenol, Band-Aid and Listerine – from its pharmaceutical and medical device units. The latter two companies will retain the Johnson & Johnson name and be more closely aligned with each other, JNJ said.

Sign up for Kiplinger’s FREE Closing Bell email newsletter: our daily look at the most important stocks in the stock market and what actions investors should take.

J & J’s intention – as is pretty much always the case with these kinds of breakups – is to free the faster growing, higher margin companies from the weight of slower growing, lower margin companies.

We’ve seen a lot of that lately, especially with some of the investor favorite blue-chip dividend stocks, which J&J certainly qualifies. This Dow Jones component is as reliable a dividend producer as it gets. He is also a member of the S&P 500 Dividend Aristocrats, having increased its payouts for 59 consecutive years.

It remains to be seen which of the resulting companies would inherit the Dividend Aristocrats membership card from J&J.

Large, first-rate breaks

As for General Electric, which announced its own separation just a day before the JNJ news broke, of course, that’s not what it used to be. But it remains in the trend. It is an iconic dividend stock and was an original member of the Dow, dating back to 1896. Granted, GE was pulled from the Dow in 2018, but it has retained at least some of its blue chip shine. .

Then there is Big Blue. International Business Machines (IBM, $ 120.27) is both a Dow stock and a member of the Dividend Aristocrats, with a 26-year dividend growth streak. It gained momentum with the acquisition of Red Hat for $ 34 billion in 2019. The deal is supposed to help the legacy tech company compete in the lucrative cloud services industry. Thus, IBM’s spin-off of its boring managed infrastructure services unit – called Kyndryl Holdings (KD, $ 21.30) – was a logical next step.

Or consider the case of AT&T (T, $ 24.92). T is no longer in the Dow Jones, having been removed from the average (for the third time in its history) in 2015. Although he is still a dividend aristocrat at the cost of 36 consecutive years of dividend growth, this sequence seems to come to an end. The telecommunications giant separated DirecTV and WarnerMedia earlier this year. Without contributions from these companies, AT & T’s dividend will naturally have to decline, analysts say.

Return to the health sector, Merck (MRK, $ 84.02) is a Dow stock with a decade of annual dividend growth to its credit. Earlier this year, the pharmaceutical giant split off from its listed women’s health business Organon (ORG, $ 34.72).

Indeed, JNJ is only following in the footsteps of Merck and the old Dow stock. Pfizer (PFE, $ 50.18), both of whom have already moved to free themselves from their less profitable businesses. Pfizer, for example, split Upjohn in 2020 and merged it with Mylan to form Viatris (VTRS, $ 14.46).

Viatris’ portfolio includes some of the best selling drugs of all time, such as Lipitor and Viagra. But mature, non-patented drugs are not known for their dramatic margin and growth profiles.

We could go on, but the bottom line for dividend investors is that the multifaceted companies that once produced both income and growth are increasingly divided to release value. And in turn, this forces investors to decide which parts of these legacy companies (if any) to continue to own.

Stock prices are as of November 11.


Source link

]]>
Bucharest stock indices sink further, TeraPlast leads blue chip declines https://sweetasabiscuit.com/bucharest-stock-indices-sink-further-teraplast-leads-blue-chip-declines/ https://sweetasabiscuit.com/bucharest-stock-indices-sink-further-teraplast-leads-blue-chip-declines/#respond Tue, 09 Nov 2021 16:06:00 +0000 https://sweetasabiscuit.com/bucharest-stock-indices-sink-further-teraplast-leads-blue-chip-declines/ BUCHAREST (Romania), Nov. 9 (SeeNews) – Most of the Bucharest Stock Exchange (BVB) stock indexes continued to lose ground on Tuesday as PVC pipe and fittings manufacturer TeraPlast SA [BSE:TRP] drove blue chip declines, according to stock exchange data. Total turnover of BVB shares stood at some 33.5 million lei ($ 7.8 million / € […]]]>

BUCHAREST (Romania), Nov. 9 (SeeNews) – Most of the Bucharest Stock Exchange (BVB) stock indexes continued to lose ground on Tuesday as PVC pipe and fittings manufacturer TeraPlast SA [BSE:TRP] drove blue chip declines, according to stock exchange data.

Total turnover of BVB shares stood at some 33.5 million lei ($ 7.8 million / € 6.8 million) on Tuesday, compared with 90.95 million lei on Monday, according to the BVB website.

Prime lender Banca Transilvania [BSE:TLV] share price fell 0.78% to 2.5550 lei in the largest trading turnover during the session, from 6.7 million lei.

TeraPlast led the blue chip declines, with its share price falling 3.59% to 1.0740 lei lei in the second highest daily turnover of 4.73 million lei.

Blue-chip Nuclearelectrica [BSE:SNN], the operator of Romania’s only Cernavoda nuclear power plant, lost 1.23% to 44.1 lei in the third day’s turnover of 4.38 million lei.

Details follow:

BET 12,847.75 -0.10%
BET-TR 22,732.31 -0.10%
BET-FI 51 555.62 -0.52%
PARI-NG 892.30 -0.17%
PARI-XT 1134.36 -0.12%
PARI-XT-TR 2,006.49 -0.13%
PARI-BK 2,546.74 -0.02%
ROTX 27,494.37 0.00%
BETAeRO 1,023.32 -0.68%

BET is the first index developed by BVB and represents the benchmark index for the local capital market. The BET reflects the performance of the most traded companies on the BVB regulated market, excluding financial investment companies (SIF). It now includes 20 companies.

BET-TR is the first total return index launched by BVB. It is based on the structure of the benchmark BET market index. BET-TR tracks changes in the price of its component shares and is adjusted to also reflect dividends paid by the constituent companies.

BET-FI is the first sector index launched by the BVB and reflects the price variations of RIS and other similar entities.

BET-BK has been designed to be used as a benchmark by asset managers and other institutional investors.

BET-NG is a sector index which reflects the evolution of all companies listed on BVB’s regulated market included in the energy and related utilities sector. The maximum index weight that a company can hold is 30%.

BET-XT tracks the price movements of the 25 most listed companies on the BVB regulated market, including RIS.

BET-XT-TR is the total return version of the BET-XT index, which includes the 25 most traded Romanian companies listed on the BVB.

ROTX is an index developed by BVB in collaboration with the Vienna Stock Exchange. It follows, in real time, the price changes of blue chip shares traded on the Bucharest Stock Exchange.

BET AeRO is the first index for the AeRO market developed by BVB that reflects the price performance of representative companies listed on the AeRO market that meet the criteria of liquidity and free float market capitalization. It is a free float market capitalization weighted index, with a maximum weighting of 15% for any component of the index.

(1 euro = 4.9482 lei)

Banca Transilvania SA is one of the largest banks in South East Europe. For more references, take a look at the Top 100 Banks


Source link

]]>
https://sweetasabiscuit.com/bucharest-stock-indices-sink-further-teraplast-leads-blue-chip-declines/feed/ 0